Should Biotechnology Stock CorMedix Inc. (CRMD) Be in Your Portfolio Monday?

CorMedix Inc. (CRMD) is around the top of the Biotechnology industry according to InvestorsObserver. CRMD received an overall rating of 60, which means that it scores higher than 60 percent of all stocks. CorMedix Inc. also achieved a score of 81 in the Biotechnology industry, putting it above 81 percent of Biotechnology stocks. Biotechnology is ranked 71 out of the 148 industries.

CRMD has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on CRMD!

See Full CRMD Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 60 means the stock is more attractive than 60 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With CorMedix Inc. Stock Today?

CorMedix Inc. (CRMD) stock is trading at $3.90 as of 11:33 AM on Monday, Sep 11, a rise of $0.19, or 5.27% from the previous closing price of $3.70. The stock has traded between $3.80 and $3.96 so far today. Volume today is below average. So far 236,848 shares have traded compared to average volume of 462,721 shares. Click Here to get the full Stock Report for CorMedix Inc. stock.